Concepedia
Statistics
Publications
31
Citations
3.9K
H-Index
25
Active since
1984
Affiliations
The Ohio State University(Current)
National Cancer Institute
Johns Hopkins University
Palmetto Hematology Oncology
Walter Reed Army Institute of Research
Michael R. Grever is an author at The Ohio State University specializing in medicine, pharmacology, and oncology.
Top concepts
MedicinePharmacologyOncologyDrug DiscoveryCancer ResearchPathologyHematologyBiochemistryImmunotherapyChromatography
Publications per year
1984–2010
The National Cancer Institute: cancer drug discovery and development program.
Michael R. Grever, Saul A. Schepartz, B A Chabner · PubMed · 1992 · 721 citations
Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working group
Bruce D. Cheson, John M. Bennett, R. Kanti et al. · American Journal of Hematology · 1988 · 407 citations
Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia
Neil E. Kay, Susan M. Geyer, Timothy G. Call et al. · Blood · 2006 · 293 citations · Full text
Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study.
Michael R. Grever, Kenneth J. Kopecky, M K Foucar et al. · Journal of Clinical Oncology · 1995 · 267 citations
Guidelines for the Development and Incorporation of Biomarker Studies in Early Clinical Trials of Novel Agents
Janet Dancey, Kevin K. Dobbin, Susan Groshen et al. · Clinical Cancer Research · 2010 · 254 citations · Full text
Biomarker Studies, Novel Agents, Biomarker (Medicine) +17
1–5 of 31